InsidersTradesSigma
Browse the complete record of transactions filed by SAHNI PAYAL, Chairman & CEO. Officer active across 1 companies, notably PFIZER INC. Cumulatively, 3 disclosures have been published. Total volume traded: €68k. The latest transaction was disclosed on 13 May 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations
Payal Sahni is the President and Chief Executive Officer of Pfizer Inc. She oversees the company's global operations, focusing on innovation and research in the pharmaceutical sector. With a strong background in management and strategy, she is committed to advancing Pfizer's mission to improve the health and well-being of patients worldwide.